Cit Barefoot Running Strikes Back

  • Upload
    pop-dan

  • View
    214

  • Download
    0

Embed Size (px)

Citation preview

  • 8/10/2019 Cit Barefoot Running Strikes Back

    1/2

    BIOMECHANICS

    Barefoot running strikes backWilliam L. Jungers

    Detailed analyses of foot kinematics and kinetics in barefoot and shod runners offer a refined understanding

    of bipedalism in human evolution. This research will also prompt fresh studies of running injuries.

    A commitment to walking and running ontwo legs distinguishes humans from apes, andhas long been the defining adaptation of thehominins the lineages that include bothhumans and our extinct relatives. This formof locomotion (bipedalism) has been around

    for millions of years, and we have been unshodfor more than 99% of that time1. The uniquelyspecialized anatomy of the human foot2is thusa product of barefoot bipedalism, which is stillthe norm in parts of the world. Lieberman andcolleagues biomechanical research on thesubject (page 531 of this issue)3, therefore hasimplications for interpreting human evolu-tion. It also has some potentially useful andthought-provoking implications for sportsmedicine and running-shoe design. (Full dis-closure: I dont run any more, either barefootor in shoes.)

    Most shod runners today make initial con-

    tact with the ground heel-first (rear-foot strik-ing, or RFS). Experienced barefoot runners,like the ones observed for this study3, land onthe ground in many ways depending on theconditions sometimes RFS, but more oftenavoiding landing heel-first because it hurtsowing to repetitive, high-impact forces (ortransients). A more anterior landing on a flatfoot (mid-foot striking, or MFS), or on the lat-eral ball of the foot (fore-foot striking, or FFS),has predictable, and some would say desirable,consequences for pedal biomechanics. In FFSand some MFS, the foots centre of pressurenecessarily starts more anterior at contact

    and then moves backward briefly before mov-ing forward again for toeing-off. (Sprinters,whether shod or not, also run on their forefeet,but for different mechanical reasons.) Amongother differences, FFS barefoot runners tend totake shorter strides and to run with greater ver-tical leg and ankle compliance (the lowering ofthe bodys centre of mass relative to the force ofthe impact). This serves to blunt the transientforce and results in a less jarring, smootherride. The elevated and cushioned heel of mostmodern running shoes is designed for comfort,stability and to attenuate the transient forces ofheel-strike in RFS running that may be linked

    to some orthopaedic injuries.Lieberman and colleagues multifaceted

    study3corroborates and extends what is knownabout the basic mechanics of barefoot running,as they develop a collisional model of the footand leg as an L-shaped double pendulum withthe same dimensions as a typical shank andfoot. They then calculate how much energysuch a pendulum exchanges with the groundwhen it collides at different points and with astiff or compliant ankle. They also broaden thecomparative human database by studying thephenomenon not only in long-term, habitual

    barefoot runners in a laboratory setting but alsoon the runners home turf in Africa (Fig. 1).They find that FFS (and some MFS) reducesthe effective mass of the foot and converts sometranslational energy into rotational energy;the calf muscles control heel drop, and theFFS runner can take fuller advantage of elasticenergy storage in both the Achilles tendon andthe longitudinal arch of the foot. FFS and MFSrunners therefore require more calf- and foot-muscle strength, but avoid uncomfortable andpotentially injurious impact transients evenwhen barefoot on very hard surfaces.

    The findings of this study complement and

    strengthen Bramble and Liebermans influ-ential endurance-running hypothesis (ERH)

    for the transformation of the human bodyplan with the emergence of the genus Homo4.The much earlier australopithecine version ofbipedalism (as seen in Lucy,Australopithecusafarensis) was long-lived and a great successby any standard. However, this skeletal designreceived a major make-over near the Pliocene/Pleistocene boundary about 2 million yearsago. Longer hindlimbs and shorter toes arepart of this new package, and if the ERH is cor-rect, the evolution of these features along with

    a fully arched foot is probably linked directlyto barefoot running as an integral part of anadaptive strategy for pursuit hunting5,6. Theaustralopithecine bare foot was well-suitedfor heel-to-toe walking and perhaps for short,rapid bursts of sprinting7. But Lucy was not amarathoner.

    The blogosphere and popular magazinesare full of debate about barefoot running, withtestimonials to it as a more natural and lessinjury-prone style, and often with a nod to theERH and an appeal to the evolutionary primacyof the unshod foot. Sometimes barefoot advo-cacy can take on evangelical overtones8. But it

    is also clear that running-shoe companies andother footwear designers are paying attention,

    Figure 1 |Different footfalls. These photos are of two Kalenjin runners from Kenya, a barefoot12-year-old girl (left) and a boy of the same age in running shoes. Note the differences in foot

    angulation as the girl prepares for a forefoot touchdown and the boy prepares to land heel first.(Photos courtesy of D. E. Lieberman.)

    433

    Vol 463|28 January 2010

    NEWS & VIEWS

    20 Macmillan Publishers Limited. All rights reserved10

  • 8/10/2019 Cit Barefoot Running Strikes Back

    2/2

    and they should take note of this new study3.Barefoot-like designs for footwear are cur-rently the rage, even if they still constitute onlya small slice of the enormous running-shoeindustry. Many shod runners never developinjuries, but the available data indicate that atleast some (1979%) do9. Although there is nohard proof that running in shoes, especially hi-tech or PCECH (pronation control, elevated

    cushioned heel) versions, causes injuries, inmy view there is no compelling evidence thatit prevents them either10,11. However, there aredata that implicate shoes more generally as aplausible source of some types of chronic footproblems12,13.

    More studies like that of Lieberman et al.3are required to provide data instead of opinion,and testablemodels and scientific explanationinstead of anecdotes. It is also apparent that acarefully designed biomedical study with anevidence-based approach is badly needed toassess the competing claims as to what, if any-thing, is the best cover for a runners foot. It will

    be interesting to see where the next foot falls,and how it is wrapped. William L. Jungers is in the Department

    of Anatomical Sciences, Stony Brook

    University Medical Center, Stony Brook,

    New York 11794-8081, USA.

    e-mail: [email protected]

    1. Trinkaus, E.J. Arch. Sci.32,15151526 (2005).

    2. Klenerman, L. & Wood, B. A.The Human Foot: A Companionto Clinical Studies(Springer, 2006).

    3. Lieberman, D. E. et al.Nature463,531535 (2010).

    4. Bramble, D. M. & Lieberman, D. E.Nature432,345352

    (2004).

    5. Rolian, C. et al.J. Exp. Biol.212,713721 (2009).

    6. Lieberman, D. E., Bramble, D. M., Raichlen, D. A. & Shea,

    J. J. in The First Humans(eds Grine, F. E., Fleagle, J. G. &

    Leakey, R. E.) 7798 (Springer, 2009).

    7. Lee, S. S. M. & Piazza, S. J.J. Exp. Biol.212,37003707 (2009).

    8. McDougall, C. Born to Run: A Hidden Tribe, Superathletes, and

    the Greatest Race the World Has Never Seen(Knopf, 2009).

    9. van Gent, R. N. et al.Br. J. Sports Med.41,469480 (2007).

    10. Richards, C. E., Magin, P. J. & Callister, R. Br. J. Sports Med.

    43,159162 (2009).

    11. Kerrigan, D. C. et al.PM&R1,10581063 (2009).

    12. Rao, U. B. & Joseph, B.J. Bone Joint Surg.74B,525527 (1992).

    13. Zipfel, B. & Berger, L. R.The Foot17,205213 (2007).

    because they lack the typical T-cell surfacereceptor and do not respond to antigens. Theydo, however, respond to IL-2, in line with theirexpression of the common -chain receptor,which functions as the signalling componentof the IL-2 receptor.

    Moro and colleagues4name these cellsnatural helper cells and, on the basis of similaractivation properties5, draw analogies with the

    natural killer cell (NK cell) a type of lym-phocyte that forms part of the innate immunedefence against viruses and tumour cells, andthat responds to cytokine stimulation and/orcell-surface components rather than specificantigens. However, natural helper cells lackNK-cell-lineage markers and, unlike NKcells, bear receptors commonly found on pro-genitor (rather than differentiated) cells, suchas the IL-7 receptor and stem-cell-factor recep-tor (c-Kit). In view of these characteristics, itmight be more accurate to call these cellsnatural TH2 cells.

    The abundance of these cells is limited by

    the small size and number of FALCs. Neverthe-less, their strategic location and the particu-lar cytokines that they secrete endow themwith considerable functional impact. Indeed,Moro et al.4show that, in mice, these cells helpto combat infection with the hookworm-likehelminth parasite Nippostrongylus brasiliensisby inducing proliferation of B cells in Peyerspatches (lymph-node-like structures in thegut wall) and mucus formation, which helpsto expel worms from the gut (Fig. 1).

    The natural helper cells produce IL-5 andIL-13 in response to IL-25 (and IL-2), and alsoin response to IL-33, an atypical cytokine that

    activates the cell through the ST2 receptor6

    (Fig. 1). IL-33 is secreted largely by non-lym-phoid cells such as endothelial cells that lineblood vessels, epithelial cells, fibroblasts and,

    IMMUNOLOGY

    The expanding TH2 universeWarren Strober

    TH2 growth factors, which are involved in allergy and in defence against

    parasites, are produced by many different cell types, including a newly

    identified population found in fat-associated lymph clusters in the abdomen.

    It is almost 25 years since the publication ofMosmann and Coffmans seminal work1thatdefined two main subtypes of helper T lym-phocyte: TH1 cells and TH2 cells. The TH2 cellsof this dichotomy were shown to produce acollection of growth factors (cytokines) andcell-attractant molecules (chemokines) that areinvolved in mediating allergic responses andhost defence against parasitic infection. But theproperties of the original TH2 T lymphocyte arenow known to be shared by several differentcell types. For instance, a recently reported sub-population of T cells, TH9 T cells

    2, produce IL-9and IL-10 TH2-type cytokines that exacer-

    bate allergic inflammation. In addition, cellsthat produce IL-25 (macrophages, epithelialcells and mast cells) induce others to secretethe TH2-type cytokines IL-5 and IL-13, andchemoattractants of eosinophils inflamma-tory cells that contribute to allergic diseases andTH2-type host defences

    3. Thus, we currentlythink of TH2 not so much in the context ofa cell, but rather as a function or, in businessparlance, a franchise. On page 540 of this issue,another cell contributing to the TH2 franchiseis reported by Moro and colleagues4.

    The authors detected the new cell popula-tion in previously overlooked fat-associated

    lymphoid clusters (FALCs), which are scat-tered along the blood vessels in the peritoneal

    mesentery (a vascular membrane that sur-rounds part of the intestine in the abdomen).The researchers show that these cells do pro-duce TH2 cytokines, but that they are not T cells

    Figure 1 |Newly discovered natural helper cells. a, Moro and colleagues4identify a population ofcells producing TH2-type cytokines in tiny accumulations of lymphoid cells, termed fat-associatedlymphoid clusters (FALCs), in the mesentery. b, These cells can be stimulated by the cytokines IL-25and IL-2 and by the atypical cytokine IL-33, which signals the cell through the ST2 receptor. Naturalhelper cells produce TH2 cytokines, including IL-13, inducing proliferation of B lymphocytes inPeyers patches and the production of mucus, factors that counter infection with helminth worms. The

    cytokines produced by natural helper cells also support B1-lymphocyte maintenance and productionof antibodies by B cells in the spleen.

    a b

    Artery

    Colon

    Mesentery

    FALC

    Natural helper cell

    (natural TH2 cell)

    B1-B cell

    (in peritoneal

    cavity)

    Peyers patch

    (mucosal

    lymph node)

    Villi

    IL-33

    IL-13

    IL-2

    IL-25

    ST2

    IL-13

    r ery

    Colon

    tery

    C

    Intestine

    Lumen

    Mucus

    434

    NATURE|Vol 463|28 January 2010NEWS & VIEWS

    20 Macmillan Publishers Limited. All rights reserved10